InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,841.47
(
-0.02%
)
US TECH 100
19,694.00
(
0.29%
)
Dow Jones
43,239.05
(
0.37%
)
Brent Oil
74.42
(
0.36%
)
Bitcoin
67,217.03
(
-0.30%
)
Post# of 253393
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

bladerunner1717

Send PM Follow Ignore
Followers 38
Posts 5652
Boards Moderated 0
Alias Born 11/09/2003

bladerunner1717

Re: pcrutch post# 126736

Monday, 09/19/2011 11:48:14 AM

Monday, September 19, 2011 11:48:14 AM

Post# of 253393
Momenta Pharma (MNTA) Shares Sink as Amphastar Pharma Gets FDA Approval for Generic Lovenox -WSJ

More News related to MNTA

Momenta Pharma (MNTA) Shares Sink as Amphastar Pharma Gets FDA Approval for Generic Lovenox -WSJ


Momenta Pharma (MNTA) Shares Sink as Amphastar Pharma Gets FDA Approval for Generic Lovenox -WSJ
Prana (PRAN) Reports Publication of Positive Data for PBT2 on Restoring Cognitive Function in Alzheimer's Patients
Aastrom (ASTM) Reports Encouraging Results of IMPACT-DCM from 12-Month Follow Up
Marshall Edwards (MSHL) Doses First Patient in ME-143 Phase I
Adeona (AEN) Completes Enrollment in Trimesta Trial; Receives Additional Funding

More News related to FDA
September 19, 2011 11:18 AM EDT

Shares of Momenta Pharma (Nasdaq: MNTA) are plunging following a WSJ headline which reports Amphastar Pharma has received FDA approval for the generic version of Lovenox.

Bladerunner
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up